Gilead Sciences Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2016
Total Assets: $56.98B
Liabilities Breakdown FY2016
Total Liabilities: $38.09B
Asset Breakdown
Total Assets: $56.98B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.23B | 14.4% |
| Accounts Receivable | $4.51B | 7.9% |
| Inventory | $1.59B | 2.8% |
| Property, Plant & Equipment | $2.87B | 5.0% |
| Goodwill | $1.17B | 2.1% |
| Intangible Assets | $8.97B | 15.7% |
| Other Assets | $29.64B | 52.0% |
Liabilities Breakdown
Total Liabilities: $38.09B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.21B | 3.2% |
| Long-Term Debt | $26.35B | 69.2% |
| Other Liabilities | $10.54B | 27.7% |